股价翻6倍业绩却崩盘,基石药业从Biopharma撤退,选择对了吗?

Ofweek维科网
Aug 19, 2025

从Biotech成为Biopharma,可以说是大多数创新药企的终极目标。前者以生物技术研发为核心,专注于药物发现、临床前研究、临床试验等,通常缺乏完整的生产和销售体系,依赖技术平台和创新管线吸引投资或合作。后者则覆盖药物全生命周期(研发到生产到商业化),拥有规模化生产能力和成熟的销售网络,通过已上市产品获得稳定收入,并反哺研发管线扩展。不难看出,Biopharma具备更加完整的产业链,实现了...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10